Free Trial

Capital Fund Management S.A. Has $1.82 Million Stock Position in MaxLinear, Inc. (NASDAQ:MXL)

MaxLinear logo with Computer and Technology background

Capital Fund Management S.A. lessened its position in shares of MaxLinear, Inc. (NASDAQ:MXL - Free Report) by 31.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 91,841 shares of the semiconductor company's stock after selling 42,135 shares during the quarter. Capital Fund Management S.A. owned about 0.11% of MaxLinear worth $1,817,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Raymond James Financial Inc. purchased a new stake in MaxLinear during the fourth quarter worth about $1,671,000. Aster Capital Management DIFC Ltd acquired a new position in MaxLinear during the 4th quarter valued at approximately $34,000. Hel Ved Capital Management Ltd acquired a new stake in MaxLinear in the fourth quarter worth approximately $3,317,000. ExodusPoint Capital Management LP purchased a new stake in shares of MaxLinear in the 4th quarter valued at approximately $1,859,000. Finally, Trexquant Investment LP bought a new position in MaxLinear during the fourth quarter valued at approximately $306,000. 90.79% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have issued reports on MXL. Benchmark cut their price objective on MaxLinear from $28.00 to $20.00 and set a "buy" rating for the company in a research report on Tuesday, April 15th. Northland Securities boosted their price target on MaxLinear from $25.00 to $27.50 and gave the stock an "outperform" rating in a report on Monday, January 6th. Stifel Nicolaus cut their price objective on shares of MaxLinear from $26.00 to $16.00 and set a "buy" rating on the stock in a research report on Thursday. Wells Fargo & Company raised their target price on MaxLinear from $19.00 to $20.00 and gave the company an "equal weight" rating in a research report on Thursday, January 30th. Finally, Susquehanna reduced their price objective on shares of MaxLinear from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, January 30th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $22.36.

Get Our Latest Report on MaxLinear

MaxLinear Price Performance

MXL traded down $0.60 on Monday, hitting $9.62. 121,287 shares of the company were exchanged, compared to its average volume of 1,376,698. The business's fifty day moving average is $12.71 and its 200 day moving average is $15.88. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.28 and a current ratio of 1.77. The firm has a market capitalization of $814.18 million, a P/E ratio of -3.30 and a beta of 1.82. MaxLinear, Inc. has a fifty-two week low of $8.35 and a fifty-two week high of $26.59.

MaxLinear (NASDAQ:MXL - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The semiconductor company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.13) by ($0.14). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. As a group, sell-side analysts anticipate that MaxLinear, Inc. will post -0.37 EPS for the current year.

MaxLinear Company Profile

(Free Report)

MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.

Further Reading

Institutional Ownership by Quarter for MaxLinear (NASDAQ:MXL)

Should You Invest $1,000 in MaxLinear Right Now?

Before you consider MaxLinear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.

While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines